WNX — Wellnex Life Share Price
Last trade - 00:00- £8.51m
- £14.31m
- AU$16.64m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 32.28 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.82 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 2.24 | ||
| Price to Sales | 0.77 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -317.98% | ||
| Return on Equity | -240.96% | ||
| Operating Margin | -43.61% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 0.99 | 1.2 | 18.61 | 27.88 | 16.64 | 24.7 | 34.6 | 72.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Wellnex Life Limited is an Australia-based health and wellness company, which is engaged in the consumer healthcare business. The Company is developing, licensing, and marketing registered products and brands to customers in the healthcare market segment. Its brands include Wakey Wakey, Nighty Night, Pharmacy Own, Mr Bright and Pain Away. The Company has intellectual property (IP)-licensing agreements with Haleon and Arrotex. The Company, through a joint venture with OneLife Botanical and Chemist Warehouse for SAS-B medicinal cannabis under the Wellness Life brand. It has launched a Therapeutic Goods Administration (TGA)-approved soft gel liquid paracetamol product in a jointly owned brand with retailer Chemist Warehouse under the Wagner Liquigesic brand. Mr Bright is a natural tooth whitening brand, which is being sold in the United Kingdom through Boots and TJ Maxx retail stores and is available online domestically.
Directors
- George Karafotias CFO
- Mark McCammon VPR
- Angela Coppola OTH
- Yifang Wang Yvette OTH
- Li Zheng SEC
- Zlatko Bozinovski DRC
- Eric Jiang NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 6th, 2011
- Public Since
- March 15th, 2017
- No. of Shareholders
- 4,911
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- London Stock Exchange
- Shares in Issue
- 68,199,722
- Address
- 17 / 71 Victoria Crescent, Abbotsford, MELBOURNE, 3207
- Web
- https://wellnexlife.com.au/
- Phone
- +61 383999419
- Auditors
- William Buck Audit (Vic) Pty Ltd
Latest News for WNX
Upcoming Events for WNX
Full Year 2025 Wellnex Life Ltd Earnings Release
Wellnex Life Ltd Annual Shareholders Meeting
Similar to WNX
Angling Direct
London Stock Exchange
AO World
London Stock Exchange
Applied Nutrition
London Stock Exchange
Boohoo
London Stock Exchange
Burberry
London Stock Exchange
FAQ
As of Today at 24:04 UTC, shares in Wellnex Life are trading at 15.50p. This share price information is delayed by 15 minutes.
Shares in Wellnex Life last closed at 15.50p and the price had moved by over the past 365 days. In terms of relative price strength the Wellnex Life share price has matched the FTSE All Share Index by over the past year.
The overall consensus recommendation for Wellnex Life is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWellnex Life does not currently pay a dividend.
Wellnex Life does not currently pay a dividend.
Wellnex Life does not currently pay a dividend.
To buy shares in Wellnex Life you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 15.50p, shares in Wellnex Life had a market capitalisation of £8.51m.
Here are the trading details for Wellnex Life:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: WNX
Based on an overall assessment of its quality, value and momentum Wellnex Life is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Wellnex Life is 0.43p. That is 97.21% below the last closing price of 15.50p.
Analysts covering Wellnex Life currently have a consensus Earnings Per Share (EPS) forecast of -AU$0.09 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wellnex Life. Over the past six months, its share price has matched the FTSE All Share Index by .
As of the last closing price of 15.50p, shares in Wellnex Life were trading -15.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Wellnex Life PE ratio based on its reported earnings over the past 12 months is 32.28. The shares last closed at 15.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Wellnex Life's management team is headed by:
- George Karafotias - CFO
- Mark McCammon - VPR
- Angela Coppola - OTH
- Yifang Wang Yvette - OTH
- Li Zheng - SEC
- Zlatko Bozinovski - DRC
- Eric Jiang - NID